A new gel to help diabetic wounds heal faster
Engineering Injectable Microporous Hydrogels for Diabetic Wound Repair
['FUNDING_R01'] · UNIVERSITY OF VIRGINIA · NIH-11121931
This project is developing a special injectable gel to help people with diabetes heal their wounds more quickly.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF VIRGINIA (nih funded) |
| Locations | 1 site (CHARLOTTESVILLE, UNITED STATES) |
| Trial ID | NIH-11121931 on ClinicalTrials.gov |
What this research studies
We are creating an advanced injectable gel, called MAP gel, made from tiny building blocks that assemble inside the body to form a supportive structure. This gel is designed to help wounds heal better by reducing inflammation, preventing the gel from breaking down too quickly, and encouraging new blood vessel growth. These are common challenges in treating diabetic wounds. By improving these specific properties, we hope to significantly speed up the healing process for patients.
Who could benefit from this research
Good fit: Patients with slow-healing diabetic wounds, particularly those facing challenges with inflammation or poor tissue regeneration, could potentially benefit from this future treatment.
Not a fit: Patients without diabetic wounds or those whose wounds heal well with current treatments may not see additional benefit from this specific approach.
Why it matters
Potential benefit: If successful, this new gel could offer a faster and more effective way to heal chronic diabetic wounds, potentially preventing serious complications.
How similar studies have performed: This project builds upon a newly invented class of hydrogel biomaterials and introduces novel strategies to improve wound healing.
Where this research is happening
CHARLOTTESVILLE, UNITED STATES
- UNIVERSITY OF VIRGINIA — CHARLOTTESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GRIFFIN, DONALD RICHIERI — UNIVERSITY OF VIRGINIA
- Study coordinator: GRIFFIN, DONALD RICHIERI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.